Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
4.420
-0.060 (-1.34%)
At close: May 6, 2026, 4:00 PM EDT
4.610
+0.190 (4.30%)
Pre-market: May 7, 2026, 5:20 AM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$781,109
Market Cap
2.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | -2 | -15.38% |
| Dec 31, 2024 | 13 | -8 | -38.10% |
| Dec 31, 2023 | 21 | -6 | -22.22% |
| Dec 31, 2022 | 27 | 7 | 35.00% |
| Dec 31, 2021 | 20 | 2 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| HCW Biologics | 36 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| Soligenix | 14 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
| Adial Pharmaceuticals | 5 |
BDRX News
- 4 weeks ago - Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies - GlobeNewsWire
- 5 weeks ago - Preliminary Results for the Year Ended 31 December 2025 - GlobeNewsWire
- 6 weeks ago - Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group - GlobeNewsWire
- 7 weeks ago - ADR Ratio Change - GlobeNewsWire
- 2 months ago - Biodexa Announces Support for Life's a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients - GlobeNewsWire
- 2 months ago - Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer - Accesswire
- 3 months ago - Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST - GlobeNewsWire
- 4 months ago - Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary - GlobeNewsWire